A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Eating well can help support your immune system and maintain strength and energy if you have HER2-negative breast cancer, ...

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...

Early and late responders with esophageal squamous cell carcinoma experienced comparable OS benefits with Tevimbra plus chemo ...

Liana Werner-Gray began a cancer battle 15 years ago — and she believes that if she had not made substantial changes to her diet and lifestyle, she might not be alive today. Fox News Digital ...

(RTTNews) - The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult ...

The combination of nivolumab/ipilimumab did not significantly improve OS compared with chemotherapy in patients with advanced gastric, gastroesophageal junction, or esophageal cancer. In Western ...

HER2-low or HER2-ultralow metastatic breast cancer following endocrine therapy.” Dave Fredrickson, Executive Vice President, Oncology Haematology Business Unit, AstraZeneca, said: “Building on the ...

Study participants with HR-positive, HER2-low or HER2-ultralow metastatic breast cancer who disease had progressed on endocrine therapy were randomly assigned to receive trastuzumab deruxtecan (n ...

Extensive research shows that drinking alcohol increases the risk of cancer, and U.S. public-health authorities are following the example of other countries in increasing public awareness about ...